Angelica Fernandes, MD
Pulmonary Disease · Newark, NJNPI 1366995771
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,526 of the $1,706 with a category attached, or 89.4%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,250, more than ten times the $14 reported in 2022. That places this record below the midpoint for pulmonary disease clinicians in NJ, where the typical reported total is $2,135.
Across 80 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$391
- GSK$318
- AstraZeneca$296
- United Therapeutics Corporation$163
- Merck$137
- Eurofins Viracor, LLC$87
- plus $313 from 8 others
What the payments were for
- Food & beverage$1,52689%
- Education$18011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $391 |
| GSK | 19 | $318 |
| AstraZeneca | 11 | $296 |
| United Therapeutics Corporation | 9 | $163 |
| Merck | 8 | $137 |
| Eurofins Viracor, LLC | 1 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Actelion Pharmaceuticals US, Inc. | 4 | $65 |
| Bayer | 4 | $59 |
| Sanofi | 3 | $49 |
| 3b Medical, Inc. | 1 | $31 |
| Gilead | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$125
How this compares
$1,706 in reported general payments places this provider in the 45th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Newark
- Richard MillerNewark$328K
- Yazan AbdeenNewark$44K
- Christina MiglioreNewark$27K
- Pratik PatelNewark$16K
- Joseph HoffmanPark Ridge$1.1M
- Reynold PanettieriNew Brunswick$1M
- Robert SussmanSummit$551K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
- Jason ShatkinParamus$282K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.